This article provides a detailed look at the operational costs of the Milestone DMA-80 evo and CV-AAS/AFS, and how they compare to ICP-MS. Managing a large contract laboratory while receiving ...
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial The economic evaluation, conducted from societal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results